US drug discovery informatics market was valued at $1,466.8 million in 2025 and is projected to reach $3,252.3 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). Drug discovery informatics in the United States encompasses the use of advanced computational modeling, data analytics, and integrated informatics platforms to support critical stages of drug development, including virtual screening, molecular docking, structure-based drug design, sequencing and target data analysis, and library and database management. 

North American eHealth market was valued at $21.4 billion in 2025 and is growing at a CAGR of 12.0% during the forecast period (2026-2035). The North American eHealth market is rapidly advancing, driven by telehealth, remote monitoring, electronic health records, and AI?enabled care. Supportive policies, strong healthcare infrastructure, and high patient adoption are accelerating digital health integration. Telemedicine and mobile health apps are increasingly used for chronic disease management and preventive care, while investments in AI and connected devices enhance efficiency and patient outcomes. Healthcare providers are further leveraging data analytics to improve decision-making and personalize treatment, and collaborations between tech companies and hospitals are fostering innovation. This combination of technology, policy support, and patient engagement positions North America as a leader in digital healthcare innovation.

US AI in e-commerce market was valued at $2,826.58 million in 2025 and is projected to reach $13,941.03 million by 2035, growing at a CAGR of 15.7% during the forecast period (2026–2035).  The US e-commerce market is experiencing significant adoption of conversational AI and virtual assistants as companies seek to enhance customer experience and operational efficiency.

UK drug discovery informatics market was valued at $242.2 million in 2025 and is projected to reach $502.1 million by 2035, growing at a CAGR of 7.6% during the forecast period (2026–2035). Drug discovery informatics in the UK involves the application of computational modeling, virtual screening, molecular docking, data integration, and advanced analytics to support drug discovery and development,

North America drug discovery informatics market was valued at $1,588.3 million in 2025 and is projected to reach $3,491.5 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). Drug discovery informatics involves the application of computational modeling, advanced data analytics, and integrated databases to enhance drug development activities, including virtual screening, molecular docking, structure-based drug design, library and database preparation, and sequencing and target data analysis. 

India drug discovery informatics market was valued at $69.7 million in 2025 and is projected to reach $207.7 million by 2035, growing at a CAGR of 11.6% during the forecast period (2026–2035). Drug discovery informatics in India involves the use of computational modeling, virtual screening, molecular docking, structure-based drug design, sequencing and target data analysis, and database management to streamline and accelerate drug development processes. 

India medical robotics market was valued at $0.2 billion in 2025 and is growing at a CAGR of 19.9% during the forecast period (2026-2035). India’s medical robotics landscape is rapidly evolving from a niche technology to a strategic component of advanced healthcare delivery. Driven by the growing demand for minimally invasive procedures and precision?focused care, robotic systems are being increasingly adopted across specialties such as urology, gynaecology, orthopaedics, and cardiac surgery, with hospitals in urban centers leading this shift. Innovations integrating AI, machine learning, and enhanced imaging are improving surgical accuracy and patient outcomes, while domestic startups are developing cost?effective, locally made solutions to broaden accessibility beyond major metros. At the same time, expanding healthcare infrastructure, rising chronic disease prevalence, and supportive public and private investments are encouraging broader deployment of robotic platforms. Despite challenges such as high upfront costs and skill shortages, training initiatives and technology?driven efficiencies are enabling more Indian institutions to embrace robotics, signalling a trend toward data?driven, patient?centric surgical care.

Global STEM toys market was valued at $6.7 billion in 2024 and is growing at a CAGR of 8.5% during the forecast period (2026-2035). As educational stakeholders increasingly emphasize hands-on learning tools that foster science, technology, engineering, and mathematics skills among children. 

Global rat model market was valued at $1.5 billion in 2025 and is growing at a CAGR of 7.6% during the forecast period (2026-2035). The market growth is driven by rising R&D in pharma/biotech, advancements in genetic engineering (like CRISPR) for creating precise models, increased focus on personalized medicine, and demand for models in drug discovery, disease modeling (oncology, neurology), and toxicology studies, with key segments including genetically engineered/knockout and humanized rats, serving academia and industry globally, particularly in North America. 

India eHealth market was valued at $1.4 billion in 2025 and is growing at a CAGR of 14.0% during the forecast period (2026-2035). The Indian eHealth market is rapidly evolving as digital technologies reshape how healthcare is delivered, accessed, and managed across the country. Increasing internet and smartphone penetration, coupled with expanding demand for affordable and convenient care, has accelerated the adoption of telemedicine, remote monitoring, and mobile health applications across urban and rural regions alike. Government-led frameworks such as the Ayushman Bharat Digital Mission and standardized telemedicine guidelines are creating interoperable systems and broader digital health infrastructure that enhance care coordination and reduce service gaps. Innovation in AI-powered diagnostics, electronic health records, and smart health platforms is enabling more patient?centric care and data?driven decision?making for providers. At the same time, continued focus on inclusivity and rural outreach is helping to bridge the long?standing divide in healthcare access. This dynamic environment fosters ongoing collaboration between public agencies, startups, and established healthcare players, positioning India’s eHealth market for sustained growth and deeper integration into mainstream care delivery.